Detalhe da pesquisa
1.
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
Lancet Oncol
; 20(2): 239-253, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30660609
2.
Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
Eur J Nucl Med Mol Imaging
; 46(2): 421-428, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30218317
3.
Correction to: Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
Eur J Nucl Med Mol Imaging
; 46(2): 533-534, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30535744
4.
Association between lung cancer somatic mutations and occupational exposure in never-smokers.
Eur Respir J
; 50(4)2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29074543
5.
Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.
Br J Clin Pharmacol
; 83(3): 623-631, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27662818
6.
18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer.
Eur J Nucl Med Mol Imaging
; 43(13): 2324-2335, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27325312
7.
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers.
Eur Respir J
; 45(5): 1403-14, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25657019
8.
Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study.
BMC Cancer
; 14: 953, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25511923
9.
Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.
Eur J Nucl Med Mol Imaging
; 40(7): 985-96, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23564036
10.
Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study.
Cancers (Basel)
; 14(7)2022 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406523
11.
Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019.
Cancers (Basel)
; 12(12)2020 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33276639
12.
Management and outcomes of non-small cell lung cancer patients with rapid progression under second-or-more-line immune checkpoint inhibitors: ERORECI study (GFPC 2016-04).
Cancer Med
; 9(2): 432-439, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31747137
13.
Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02-14.
Adv Ther
; 36(8): 2161-2166, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154630
14.
Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study).
Lung Cancer
; 136: 109-114, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31491676
15.
Safety of combined PD-1 pathway inhibition and radiation therapy for non-small-cell lung cancer: A multicentric retrospective study from the GFPC.
Cancer Med
; 7(11): 5505-5513, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30311424
16.
Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer).
ESMO Open
; 3(5): e000394, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30094074
17.
Oxaliplatin-induced bronchiolitis obliterans organizing pneumonia following hyperthermic intraperitoneal chemotherapy.
J Gastrointest Oncol
; 9(3): E15-E18, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29998025
18.
Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients.
ERJ Open Res
; 4(1)2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29450203
19.
Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.
Ann Nucl Med
; 31(2): 125-134, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27812791
20.
Off-Label Use of Crizotinib as a Neoadjuvant Treatment for a Young Patient When Conventional Chemotherapy Gave No Benefits in Stage IIIA Non-Small Cell Lung Cancer.
Am J Case Rep
; 18: 890-893, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28808224